Molecular aspects of Chikungunya virus infections in cancer patients.

Abstract

BACKGROUND. Chikungunya virus (CHIKV) is an arbovirus that can cause chronic and debilitating manifestations. The first autochthonous case in Rio de Janeiro state was diagnosed in 2015, and an outbreak was declared in 2016. OBJECTIVE. The aim of this work was to evaluate CHIKV viral load in serum, plasma and urine in cancer patients to determine the best sample in cancer patients, as well as perform molecular characterization and phylogenetic analysis of circulating strains. METHODS. Paired serum, plasma and urine collected from 31 cancer patients were tested by real-time quantitative PCR and a segment of the CHIKV E1 gene was sequenced. FINDINGS. We detected 11 CHIKV+ oncological patients. Paired samples analyses of 9 patients showed a different pattern of detection. Also, a higher viral load in plasma (6.84 log10) and serum (6.07 log10) vs urine (3.76 log10) was found. Phylogenetic analysis and molecular characterization revealed East/Central/Southern Africa (ECSA) genotype circulation and three amino acids substitutions (E1-K211T, E1-M269V, E1-T288I) in positive patients. MAIN CONCLUSION. The results indicate the bioequivalence of serum and plasma for CHIKV diagnosis, with urine being an important complement. ECSA genotype was circulating among patients in the period of the 2016 outbreak with K211T, M269V and T288I substitution.